Hensoldt's Order Book Tops €10 Billion, Yet the Stock Slips: The Market Wants to See the Money

Hensoldt's record H1 order intake and backlog fail to lift shares as investors focus on margin conversion and negative free cash flow.

The arithmetic of defense contracting can be unforgiving. Hensoldt reported a blockbuster first half on Friday — order intake doubled, the backlog crossed the €10 billion threshold for the first time, and revenue grew at a double-digit clip. The shares, however, fell 4.64 percent to close at €79.76.

That divergence tells the real story: investors are no longer rewarding the sensor and optronics specialist simply for filling its pipeline. They want to see that pipeline convert into profit.

The numbers themselves were hard to fault. Order intake for the first half of 2026 came in at €2.812 billion, more than double the €1.405 billion recorded a year earlier. The order backlog climbed 46.5 percent to €10.356 billion, giving the Oberkochen-based company a book-to-bill ratio of 2.4 — meaning it has years of revenue visibility locked in. Segment-level growth was even more striking: the Sensors division saw intake surge 57.6 percent to €1.979 billion, while Optronics nearly sextupled to €971 million.

Revenue rose 23.6 percent to €1.167 billion, with adjusted EBITDA up 28.5 percent to €137 million. The adjusted EBITDA margin ticked up to 11.8 percent. Management reaffirmed its full-year guidance of roughly €2.75 billion in revenue and an EBITDA margin between 18.5 and 19.0 percent.

That guidance is where the market's discomfort begins. Bridging the gap from 11.8 percent in the first half to the upper end of that range requires a substantial margin ramp in the second half — a steep climb that has yet to be demonstrated. The adjusted free cash flow, meanwhile, remains negative at minus €136 million, an improvement from minus €181 million but still a drain.

The valuation debate has been simmering for some time, and Friday's price action suggests a growing camp believes the stock has run ahead of itself. JPMorgan reiterated its "Neutral" rating with a price target of €85.00, explicitly citing what it calls the highest valuation in the sector. More bearish still, mwb research kept its "Sell" recommendation and €62.00 target, warning that NATO budget shifts away from land systems could pose a structural risk that extends well beyond the current quarter.

The bulls have their own ammunition. Jefferies reaffirmed "Buy" with a €94.00 target, pointing to the strong order dynamics in the second quarter. Warburg Research also kept "Buy" with a €91.00 target, noting that revenue growth is already translating into rising earnings. Insider activity adds a supportive signal: CEO Oliver Dörre purchased shares worth €67,980 in June, and CHRO Inka Tews bought approximately €20,529. BlackRock has also crossed the 3 percent voting-rights threshold and now holds 4.91 percent. The May annual general meeting approved a 10 percent dividend increase to €0.55 per share for fiscal 2025.

There is also the question of the company's largest shareholder. Leonardo CEO Lorenzo Mariani said the Italian defense group, which acquired its 25.1 percent stake in 2021 for around €606 million, has no current plans to sell. Mariani cited defense market dynamics and potential cooperation on the Eurofighter and a sixth-generation fighter jet as reasons to hold. Leonardo's own first-half results — orders up 40 percent to roughly €16 billion and net income up 74 percent — underscore the sector's strategic momentum.

One overhang remains unresolved. Hensoldt is still assessing the financial and operational impact of the termination of the F126 frigate program, a process whose outcome is not yet known. A material negative finding would complicate the margin narrative considerably.

The stock now sits 30.70 percent below its 52-week high of €115.10, set on October 3, 2025. Yet the medium-term picture is less dire than Friday's move suggests: the shares are still up 12.37 percent over the past 30 days. With a market capitalization of €9.92 billion and annualized volatility of 54.80 percent, this remains a high-beta name. The relative strength index of 54.4 points to a stock that is neither overbought nor oversold.

The coming months will test whether the record backlog can be converted into the promised margin expansion. Key milestones include the Commerzbank & ODDO Corporate Conference on September 2, the third-quarter report on November 5, and the capital markets day in London on November 10. Between now and then, the market's central question is simple: when does the order book start showing up in the profit line?